/Investor DB

Amino Collective — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Kernal Biologicskernalbio.comin𝕏Series A · Jul 2022 · $25M

Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)Burak YILMAZ(Founder)in

Co-investorsAsymmetry VenturesCivilization Ventures Management, LlcFoundersX VenturesGaingelsHOF CapitalHummingbird Ventures+13 more

Nostosnostos-genomics.comin𝕏Pre-Seed · Feb 2022

Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases.

AI & Machine LearningBiotechDigital HealthHealthtechBerlin, DE

David Gorgan(Co-founder)inRocio Acuna Hidalgo(Co-founder)in

Co-investors42CAPAcequia Capital (AceCap)Entrepreneur FirstFaberFrontline VenturesMK Venture Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.